COVID-19 Pandemic Optimism and Vaccine Willingness among an Online Sample of US Gay, Bisexual, and Other Men Who Have Sex with Men

• Published in: Vaccines (Basel) Vol. 9; no. 7; p. 745
• Main Authors: Stephenson, Rob, Sullivan, Stephen P., Pitter, Renee A., Hunter, Alexis S., Chavanduka, Tanaka MD
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 05.07.2021; MDPI
• Subjects: Age; Bisexuality; Coronaviruses; COVID-19; COVID-19 vaccines; Data collection; Ethnicity; gay and bisexual men; Health services; HIV; Human immunodeficiency virus; Minority & ethnic groups; Pandemics; Perception; Perceptions; Public health; Sex; Sexual orientation; Sexually transmitted diseases; Shelter in place; Social networks; STD; Vaccination; vaccine; Vaccines; United Kingdom > UK; United States > US; China
• ISSN: 2076-393X; 2076-393X
• DOI: 10.3390/vaccines9070745

This paper presents data from an online sample of U.S gay, bisexual, and other men who have sex with men (GBMSM), to explore the factors associated with three dimensions of vaccine beliefs: perception of the likelihood of a COVID-19 vaccine becoming available, perception of when a COVID-19 vaccine would become available, and the likelihood of taking a COVID-19 vaccine. Data are taken from the Love and Sex in the Time of COVID-19 study, collected from November 2020 to January 2021. A sample of 290 GBMSM is analyzed, modeling three binary outcomes: belief that there will be a COVID-19 vaccine, belief that the COVID-19 vaccine will be available in 6 months, and being very likely to take the COVID-19 vaccine. In contrast to other studies, Black/African Americans and GBMSM living with HIV had higher levels of pandemic optimism and were more likely to be willing to accept a vaccine. Men who perceived a higher prevalence of COVID-19 among their friends and sex partners, and those who had reduced their sex partners, were more likely to be willing to take a COVID-19 vaccine. There remained a small percentage of participants (14%) who did not think the pandemic would end, that there would not be a vaccine and were unlikely to take a vaccine. To reach the levels of vaccination necessary to control the pandemic, it is imperative to understand the characteristics of those experiencing vaccine hesitancy and then tailor public health messages to their unique set of barriers and motivations.